Adenomyosis
Conditions
Interventions
Treatment group:The patients in the treatment group were treated with 2 / 0 Prolene suture to fix LNG-IUS ( Mirena, Germany, Bayer, 52ug ) at the bottom of the uterus by two gynecologists above the ti
Control group:The control group was placed with Mirena by two gynecologists above the title of deputy director using conventional methods after the sixth needle GnRh-a treatment.
Sponsors
Jin Hua People's Hospital
Eligibility
Sex/Gender
Female
Age
30 Years to 50 Years
Inclusion criteria
Inclusion criteria: 1 ) 30 <= age <= 50 years old, women with a history of sexual life ; 2 ) Patients who met the diagnostic criteria of adenomyosis by imaging examination ; 3 ) Patients who were willing to participate in this study and signed informed consent ; 4 ) Patients with adenomyosis who refused hysterectomy. 5 ) In the past six months, hormone drugs were not used and drug therapy was agreed to be used.
Exclusion criteria
Exclusion criteria: 1 ) Patients with contraindications of progesterone therapy and hysteroscopy, including severe coagulation dysfunction, severe heart, liver, kidney disease or mental disorders ; 2 ) Female genital tuberculosis, inflammation, endometrial polyps, submucous myoma of uterus, endometrial cancer patients ; 3 ) Postmenopausal status ; 4 ) Patients with a history of LNG-IUS treatment within 1 year ; 5 ) Patients who were considered unsuitable for other reasons by medical staff.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| LNG-IUD in place time; | — |
Secondary
| Measure | Time frame |
|---|---|
| Uterine volume size;Time of post-operational vaginal bleeding;MBLS score of menstrual volume after treatment ( number of days with more menstrual volume / total number of days of menstruation × number of sanitary napkins used );VAS after treatment;LNG-IUD expulsion n(%); | — |
Countries
China
Contacts
Public ContactXu Pan
Jin Hua People's Hospital
Outcome results
None listed